首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Recent Advances inAstragalus membranaceusAnti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents
【24h】

Recent Advances inAstragalus membranaceusAnti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents

机译:黄芪抗糖尿病研究的最新进展:其植物化学成分的药理作用

获取原文
获取外文期刊封面目录资料

摘要

The disease burden of diabetes mellitus is increasing throughout the world. The need for more potent drugs to complement the present anti-diabetic drugs has become an imperative.Astragalus membranaceus, a key component of most Chinese herbal anti-diabetic formulas, has been an important prospect for lead anti-diabetic compounds. It has been progressively studied for its anti-diabetic properties. Ethnopharmacological studies have established its potential to alleviate diabetes mellitus. Recent studies have sought to relate its chemical constituents to types 1 and 2 diabetes mellitus. Its total polysaccharides, saponins, and flavonoids fractions and several isolated compounds have been the most studied. The total polysaccharides fraction demonstrated activity to both types 1 and 2 diabetes mellitus. This paper discusses the anti-diabetic effects and pharmacological action of the chemical constituents in relation to types 1 and 2 diabetes mellitus.
机译:在世界范围内,糖尿病的疾病负担正在增加。迫切需要更强效的药物来补充目前的抗糖尿病药物。黄芪是大多数中草药抗糖尿病药物的关键成分,已成为抗糖尿病先导化合物的重要前景。由于其抗糖尿病特性,已经对其进行了逐步研究。民族药理学研究已经证实其减轻糖尿病的潜力。最近的研究试图将其化学成分与1型和2型糖尿病相关。它的总多糖,皂苷和类黄酮馏分以及几种分离的化合物已被研究最多。总多糖分数显示出对1型和2型糖尿病的活性。本文讨论了与1型和2型糖尿病相关的化学成分的抗糖尿病作用和药理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号